share_log

HC Wainwright & Co. Reiterates Buy on Clearside Biomedical, Maintains $6 Price Target

HC Wainwright & Co. Reiterates Buy on Clearside Biomedical, Maintains $6 Price Target

HC Wainwright & Co.重申買入Clearside Biomedical,維持6美元的目標股價
Moomoo 24/7 ·  03/14 06:53

HC Wainwright & Co. analyst Yi Chen reiterates Clearside Biomedical (NASDAQ:CLSD) with a Buy and maintains $6 price target.

HC Wainwright & Co. 分析師陳毅重申Clearside Biomedical(納斯達克股票代碼:CLSD)的買入並維持6美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論